Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective April 1, 2025.
Hosted on MSN8h
A single dose of this drug could defeat breast cancer 💊Breast cancer, one of the most common cancers among women, could soon benefit from a new therapeutic approach. A new molecule ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback